WuXi AppTec stock: Morgan Stanley keeps HKD 207.40 target for WuXi AppTec stock

Published on 10/21/2026 at 17:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 26, 2026 at HKD 18.10 billion. WuXi AppTec stock costs EUR 22.22 on October 21, 2026 versus the Tradegate close.

Analyst target and reporting date

Morgan Stanley maintained an Overweight rating and HKD 207.40 target on October 15, 2026.
WuXi AppTec plans 800 tons of added API capacity at Changzhou.
WuXi AppTec stock costs EUR 22.22 at Lang & Schwarz on October 21, 2026 at 5:01 p.m. CEST, 0.02 percent below the Tradegate close of October 20, 2026.
Third-quarter results are scheduled for October 26, 2026, with HKD 18.10 billion revenue forecast.

WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec (ISIN CNE100003F19) has a Morgan Stanley target of HKD 207.40, while its Hong Kong share price was HKD 196.50 on October 20, 2026. The target stood 5.55 percent above that price. Morgan Stanley maintained its Overweight rating in a report dated October 15, 2026, according to Futu. The Lang & Schwarz quote was EUR 22.22 on October 21, 2026 at 5:01 p.m. CEST, 0.02 percent below the Tradegate close of October 20, 2026 at EUR 22.23.

Capacity plans support the rating

Morgan Stanley's report also described a planned Changzhou expansion for WuXi STA. The project is expected to add 800 tons of active pharmaceutical ingredient capacity and involves RMB 10.10 billion of investment, according to Futu. The report said 2026 capital expenditure guidance was RMB 7.50 billion to RMB 8.50 billion.

October 26 results carry estimates

WuXi AppTec is scheduled to report results for the quarter ended September 30, 2026, on October 26, 2026. Two analysts forecast quarterly revenue of HKD 18.10 billion, up 37.55 percent from HKD 13.16 billion, while three analysts estimate earnings per share of HKD 2.97 versus HKD 1.35 a year earlier, according to finanzen.ch.

Hong Kong range frames the quote

On October 20, 2026, the Hong Kong share traded between HKD 192.70 and HKD 200.00, with a 52-week range of HKD 106.40 to HKD 219.20. Market capitalization stood at HKD 592.40 billion and volume reached 5,240,000 shares. These figures place the share 10.34 percent below its 52-week high and 84.60 percent above its 52-week low.

CRDMO scale remains central

WuXi AppTec provides research, development and manufacturing services across Asia, Europe and North America through its integrated CRDMO platform, according to the company's investor-relations page. On October 20, 2026, PR Newswire reported that Frost & Sullivan named WuXi AppTec its 2026 Global Company of the Year in the CRDMO industry. The release also cited 741 regulatory inspections and customer audits completed in 2025 with zero critical findings.

Price and reporting date

The analyst target, capacity plan and October 26 reporting date give investors three distinct reference points for the stock. The current euro quote remains below the latest Tradegate close by 0.02 percent.

The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.